BCL2L1 and disease arising from reactivation of latent virus: Latently infected TIME cells treated with increasing amounts of A-133 showed increased cell death compared to mock infected cells treated with A-133, showing that the inhibition of Bcl-xL during KSHV latent infection also results in decreased cell survival (Fig 2C).